A Budget Impact Model for Paclitaxel-eluting Stent in Femoropopliteal Disease in France

PURPOSE: The Zilver PTX drug-eluting stent (Cook Ireland Ltd., Limerick, Ireland) represents an advance in endovascular treatments for atherosclerotic superficial femoral artery (SFA) disease. Clinical data demonstrate improved clinical outcomes compared to bare-metal stents (BMS). This analysis ass...

Descripción completa

Detalles Bibliográficos
Autores principales: De Cock, Erwin, Sapoval, Marc, Julia, Pierre, de Lissovoy, Greg, Lopes, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595477/
https://www.ncbi.nlm.nih.gov/pubmed/23073560
http://dx.doi.org/10.1007/s00270-012-0494-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595477/
https://www.ncbi.nlm.nih.gov/pubmed/23073560
http://dx.doi.org/10.1007/s00270-012-0494-x

Ejemplares similares